Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

GWAS for executive function and processing speed suggests involvement of the CADM2 gene

Subjects

Abstract

To identify common variants contributing to normal variation in two specific domains of cognitive functioning, we conducted a genome-wide association study (GWAS) of executive functioning and information processing speed in non-demented older adults from the CHARGE (Cohorts for Heart and Aging Research in Genomic Epidemiology) consortium. Neuropsychological testing was available for 5429–32 070 subjects of European ancestry aged 45 years or older, free of dementia and clinical stroke at the time of cognitive testing from 20 cohorts in the discovery phase. We analyzed performance on the Trail Making Test parts A and B, the Letter Digit Substitution Test (LDST), the Digit Symbol Substitution Task (DSST), semantic and phonemic fluency tests, and the Stroop Color and Word Test. Replication was sought in 1311-21860 subjects from 20 independent cohorts. A significant association was observed in the discovery cohorts for the single-nucleotide polymorphism (SNP) rs17518584 (discovery P-value=3.12 × 10−8) and in the joint discovery and replication meta-analysis (P-value=3.28 × 10−9 after adjustment for age, gender and education) in an intron of the gene cell adhesion molecule 2 (CADM2) for performance on the LDST/DSST. Rs17518584 is located about 170 kb upstream of the transcription start site of the major transcript for the CADM2 gene, but is within an intron of a variant transcript that includes an alternative first exon. The variant is associated with expression of CADM2 in the cingulate cortex (P-value=4 × 10−4). The protein encoded by CADM2 is involved in glutamate signaling (P-value=7.22 × 10−15), gamma-aminobutyric acid (GABA) transport (P-value=1.36 × 10−11) and neuron cell-cell adhesion (P-value=1.48 × 10−13). Our findings suggest that genetic variation in the CADM2 gene is associated with individual differences in information processing speed.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1

Similar content being viewed by others

References

  1. Green MF . Cognitive impairment and functional outcome in schizophrenia and bipolar disorder. J Clin Psychiatry 2006; 67: 3–8, discussion 36-42.

    Article  Google Scholar 

  2. Seidman LJ, Biederman J, Weber W, Hatch M, Faraone SV . Neuropsychological function in adults with attention-deficit hyperactivity disorder. Biol Psychiatry 1998; 44: 260–268.

    Article  CAS  Google Scholar 

  3. Huntley JD, Howard RJ . Working memory in early Alzheimer's disease: a neuropsychological review. Int J Geriatr Psychiatry 2009; 25: 121–132.

    Article  Google Scholar 

  4. Salthouse TA . The processing-speed theory of adult age differences in cognition. Psychol Rev 1996; 103: 403–428.

    Article  CAS  Google Scholar 

  5. Luciano M, Hansell NK, Lahti J, Davies G, Medland SE, Raikkonen K et al. Whole genome association scan for genetic polymorphisms influencing information processing speed. Biol Psychol 2011; 86: 193–202.

    Article  Google Scholar 

  6. Smith EE, Jonides J . Storage and executive processes in the frontal lobes. Science (New York, NY) 1999; 283: 1657–1661.

    Article  CAS  Google Scholar 

  7. Deary IJ, Penke L, Johnson W . The neuroscience of human intelligence differences. Nat Rev Neurosci 2010; 11: 201–211.

    Article  CAS  Google Scholar 

  8. Lee T, Henry JD, Trollor JN, Sachdev PS . Genetic influences on cognitive functions in the elderly: a selective review of twin studies. Brain Res Rev 2010; 64: 1–13.

    Article  CAS  Google Scholar 

  9. Marioni RE, Davies G, Hayward C, Liewald D, Kerr SM, Campbell A et al. Molecular genetic contributions to socioeconomic status and intelligence. Intelligence 2014; 44: 26–32.

    Article  Google Scholar 

  10. Yang J, Lee SH, Goddard ME, Visscher PM . GCTA: a tool for genome-wide complex trait analysis. Am J Hum Genet 2011; 88: 76–82.

    Article  CAS  Google Scholar 

  11. Wright M, De Geus E, Ando J, Luciano M, Posthuma D, Ono Y et al. Genetics of cognition: outline of a collaborative twin study. Twin Res 2001; 4: 48–56.

    Article  CAS  Google Scholar 

  12. Lee T, Mosing MA, Henry JD, Trollor JN, Lammel A, Ames D et al. Genetic influences on five measures of processing speed and their covariation with general cognitive ability in the elderly: the older Australian twins study. Behav Genet 2012; 42: 96–106.

    Article  Google Scholar 

  13. Cirulli ET, Kasperaviciute D, Attix DK, Need AC, Ge D, Gibson G et al. Common genetic variation and performance on standardized cognitive tests. Eur J Hum Genet 2010; 18: 815–820.

    Article  Google Scholar 

  14. Tucker-Drob EM, Reynolds CA, Finkel D, Pedersen NL . Shared and unique genetic and environmental influences on aging-related changes in multiple cognitive abilities. Dev Psychol 2014; 50: 152–166.

    Article  Google Scholar 

  15. Lee T, Mosing MA, Henry JD, Trollor JN, Ames D, Martin NG et al. Genetic influences on four measures of executive functions and their covariation with general cognitive ability: the Older Australian Twins Study. Behav Genet 2012; 42: 528–538.

    Article  Google Scholar 

  16. Sleegers K, de Koning I, Aulchenko YS, van Rijn MJ, Houben MP, Croes EA et al. Cerebrovascular risk factors do not contribute to genetic variance of cognitive function: the ERF study. Neurobiol Aging 2007; 28: 735–741.

    Article  CAS  Google Scholar 

  17. Finkel D, Reynolds CA, McArdle JJ, Hamagami F, Pedersen NL . Genetic variance in processing speed drives variation in aging of spatial and memory abilities. Dev Psychol 2009; 45: 820–834.

    Article  Google Scholar 

  18. Elgamal SA, Roy EA, Sharratt MT . Age and verbal fluency: the mediating effect of speed of processing. Can Geriatr J 2011; 14: 66–72.

    Article  Google Scholar 

  19. Deary IJ, Spinath FM, Bates TC . Genetics of intelligence. Eur J Hum Genet 2006; 14: 690–700.

    Article  CAS  Google Scholar 

  20. Deary IJ, Ritchie SJ . 10 quick questions about processing speed. Br Acad Rev 2014; 24: 4.

    Google Scholar 

  21. Payton A . The impact of genetic research on our understanding of normal cognitive ageing: 1995–2009. Neuropsychol Rev 2009; 19: 451–477.

    Article  Google Scholar 

  22. Wisdom NM, Callahan JL, Hawkins KA . The effects of apolipoprotein E on non-impaired cognitive functioning: A meta-analysis. Neurobiol Aging 2009; 32: 63–74.

    Article  Google Scholar 

  23. Zhang JP, Burdick KE, Lencz T, Malhotra AK . Meta-analysis of genetic variation in DTNBP1 and general cognitive ability. Biol Psychiatry 2010; 68: 1126–1133.

    Article  CAS  Google Scholar 

  24. Buyske S, Bates ME, Gharani N, Matise TC, Tischfield JA, Manowitz P . Cognitive traits link to human chromosomal regions. Behav Genet 2006; 36: 65–76.

    Article  Google Scholar 

  25. Rommelse NN, Arias-Vasquez A, Altink ME, Buschgens CJ, Fliers E, Asherson P et al. Neuropsychological endophenotype approach to genome-wide linkage analysis identifies susceptibility loci for ADHD on 2q21.1 and 13q12.11. Am J Hum Genet 2008; 83: 99–105.

    Article  CAS  Google Scholar 

  26. Almasy L, Gur RC, Haack K, Cole SA, Calkins ME, Peralta JM et al. A genome screen for quantitative trait loci influencing schizophrenia and neurocognitive phenotypes. Am J Psychiatry 2008; 165: 1185–1192.

    Article  Google Scholar 

  27. Seshadri S, DeStefano AL, Au R, Massaro JM, Beiser AS, Kelly-Hayes M et al. Genetic correlates of brain aging on MRI and cognitive test measures: a genome-wide association and linkage analysis in the Framingham Study. BMC Med Genet 2007; 8: S15.

    Article  Google Scholar 

  28. Cirulli ET, Kasperaviciute D, Attix DK, Need AC, Ge D, Gibson G et al. Common genetic variation and performance on standardized cognitive tests. Eur J Hum Genet 2010; 18: 815–820.

    Article  Google Scholar 

  29. Need AC, Attix DK, McEvoy JM, Cirulli ET, Linney KL, Hunt P et al. A genome-wide study of common SNPs and CNVs in cognitive performance in the CANTAB. Hum Mol Genet 2009; 18: 4650–4661.

    Article  CAS  Google Scholar 

  30. LeBlanc M, Kulle B, Sundet K, Agartz I, Melle I, Djurovic S et al. Genome-wide study identifies PTPRO and WDR72 and FOXQ1-SUMO1P1 interaction associated with neurocognitive function. J Psychiatr Res 2012; 46: 271–278.

    Article  Google Scholar 

  31. Kottgen A, Pattaro C, Boger CA, Fuchsberger C, Olden M, Glazer NL et al. New loci associated with kidney function and chronic kidney disease. Nat Genet 2010; 42: 376–384.

    Article  Google Scholar 

  32. Psaty BM, O'Donnell CJ, Gudnason V, Lunetta KL, Folsom AR, Rotter JI et al. Cohorts for Heart and Aging Research in Genomic Epidemiology (CHARGE) Consortium: Design of prospective meta-analyses of genome-wide association studies from 5 cohorts. Circ Cardiovasc Genet 2009; 2: 73–80.

    Article  Google Scholar 

  33. International HapMap Consortium, Frazer KA, Ballinger DG, Cox DR, Hinds DA, Stuve LL et al. A second generation human haplotype map of over 3.1 million SNPs. Nature 2007; 449: 851–861.

    Article  Google Scholar 

  34. Kirsch IS, Jungeblut A, Jenkins L, Kolstad A . Adult literacy in America. National Center for Education Statistics, U.S. Department of Education Office of Educational Research and Improvement: Washington, DC, USA, 2002.

    Google Scholar 

  35. Fourage D, Houtkoop W, Van der Velden R . Laaggeletterdheid in Nederland Utrecht/'s-Hertogenbosch. Expertisecentrum Beroepsonderwijs: The Netherlands, 2011 September. Report No.: Contract No.: ISBN/EAN 978-94-6052-039-6.

    Google Scholar 

  36. Calvin CM, Deary IJ, Webbink D, Smith P, Fernandes C, Lee SH et al. Multivariate genetic analyses of cognition and academic achievement from two population samples of 174,000 and 166,000 school children. Behav Genet 2012; 42: 699–710.

    Article  Google Scholar 

  37. Speliotes EK, Willer CJ, Berndt SI, Monda KL, Thorleifsson G, Jackson AU et al. Association analyses of 249,796 individuals reveal 18 new loci associated with body mass index. Nat Genet 2010; 42: 937–948.

    Article  CAS  Google Scholar 

  38. GTEx Consortium. The Genotype-Tissue Expression (GTEx) project. Nat Genet 2013; 45: 580–585.

    Article  Google Scholar 

  39. Barrett T, Wilhite SE, Ledoux P, Evangelista C, Kim IF, Tomashevsky M et al. NCBI GEO: archive for functional genomics data sets—update. Nucleic Acids Res 2013; 41: D991–D995.

    Article  CAS  Google Scholar 

  40. Edgar R, Domrachev M, Lash AE . Gene Expression Omnibus: NCBI gene expression and hybridization array data repository. Nucleic Acids Res 2002; 30: 207–210.

    Article  CAS  Google Scholar 

  41. Kanehisa M, Goto S . KEGG: kyoto encyclopedia of genes and genomes. Nucleic Acids Res 2000; 28: 27–30.

    Article  CAS  Google Scholar 

  42. Ashburner M, Ball CA, Blake JA, Botstein D, Butler H, Cherry JM et al. Gene ontology: tool for the unification of biology. The Gene Ontology Consortium. Nat Genet 2000; 25: 25–29.

    Article  CAS  Google Scholar 

  43. Croft D, Mundo AF, Haw R, Milacic M, Weiser J, Wu G et al. The Reactome pathway knowledgebase. Nucleic Acids Res 2014; 42: D472–D477.

    Article  CAS  Google Scholar 

  44. Coon KD, Myers AJ, Craig DW, Webster JA, Pearson JV, Lince DH et al. A high-density whole-genome association study reveals that APOE is the major susceptibility gene for sporadic late-onset Alzheimer's disease. J Clin Psychiatry 2007; 68: 613–618.

    Article  CAS  Google Scholar 

  45. Casey JP, Magalhaes T, Conroy JM, Regan R, Shah N, Anney R et al. A novel approach of homozygous haplotype sharing identifies candidate genes in autism spectrum disorder. Hum Genet 2012; 131: 565–579.

    Article  Google Scholar 

  46. Service SK, Verweij KJ, Lahti J, Congdon E, Ekelund J, Hintsanen M et al. A genome-wide meta-analysis of association studies of Cloninger's Temperament Scales. Transl Psychiatry 2012; 2: e116.

    Article  CAS  Google Scholar 

  47. Thomas LA, Akins MR, Biederer T . Expression and adhesion profiles of SynCAM molecules indicate distinct neuronal functions. J Comp Neurol 2008; 510: 47–67.

    Article  CAS  Google Scholar 

  48. Peters BD, Ikuta T, Derosse P, John M, Burdick KE, Gruner P et al. Age-related differences in white matter tract microstructure are associated with cognitive performance from childhood to adulthood. Biol Psychiatry 2013; 75: 248–256.

    Article  Google Scholar 

  49. Sasson E, Doniger GM, Pasternak O, Tarrasch R, Assaf Y . White matter correlates of cognitive domains in normal aging with diffusion tensor imaging. Front Neurosci 2013; 7: 32.

    Article  Google Scholar 

  50. Liu F, Arias-Vasquez A, Sleegers K, Aulchenko YS, Kayser M, Sanchez-Juan P et al. A genomewide screen for late-onset Alzheimer disease in a genetically isolated Dutch population. Am J Hum Genet 2007; 81: 17–31.

    Article  CAS  Google Scholar 

  51. Naj AC, Jun G, Beecham GW, Wang LS, Vardarajan BN, Buros J et al. Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer's disease. Nat Genet 2011; 43: 436–441.

    Article  CAS  Google Scholar 

  52. Hollingworth P, Harold D, Sims R, Gerrish A, Lambert JC, Carrasquillo MM et al. Common variants at ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer's disease. Nat Genet 2011; 43: 429–435.

    Article  CAS  Google Scholar 

  53. Wechsler D . WAIS-R Manual. Psychological Corporation: Cleveland, OH, USA, 1981.

    Google Scholar 

  54. Wechsler D . The Measurement and Appraisal of Adult Intelligence Manual for the Wechsler Adult Intelligence Scale. Psychological Corporation: New York, NY, USA, 1955.

    Google Scholar 

  55. Wechsler D . Wechsler Adult Intelligence Scale – Third Edition (WAIS III). Psychological Corporation: San Antonio, TX, USA, 1997.

    Google Scholar 

  56. Wechsler D . WAIS-IIIUK Administration and Scoring Manual London. Psychological Corporation: UK, 1998.

    Google Scholar 

  57. Jolles J, Houx PJ, Van Boxtel MPJ, Ponds RWHM . The Maastricht Aging Study: Determinants of Cognitive Aging. Neuropsych Publishers: Maastricht, Netherlands, 1995.

    Google Scholar 

  58. Smith A . Symbol Digit Modalities Test Manual - Revised. Western Psychological Services: Los Angeles, CA, USA, 1992.

    Google Scholar 

  59. Houx PJ, Shepherd J, Blauw GJ, Murphy MB, Ford I, Bollen EL et al. Testing cognitive function in elderly populations: the PROSPER study. PROspective Study of Pravastatin in the Elderly at Risk. J Neurol Neurosurg Psychiatry 2002; 73: 385–389.

    Article  CAS  Google Scholar 

Download references

Acknowledgements

3CS: The work was made possible by the generous participation of the control subjects and their families. This work was supported by the National Foundation for Alzheimer’s disease and related disorders, the Institut Pasteur de Lille, the Centre National de Génotypage, Inserm, FRC (fondation pour la recherche sur le cerveau) and Rotary. This work has been developed and supported by the LABEX (laboratory of excellence program investment for the future) DISTALZ grant (Development of Innovative Strategies for a Transdisciplinary approach to ALZheimer’s disease). JCL was funded by the MEDIALZ Project (Grant 11001003) financed by ERDF (European Regional Development Fund) and Conseil Régional Nord Pas de Calais. The Three-City Study was performed as part of a collaboration between the Institut National de la Santé et de la Recherche Médicale (Inserm), the Victor Segalen Bordeaux II University and Sanofi-Synthélabo. The Fondation pour la Recherche Médicale funded the preparation and initiation of the study. The 3C Study was also funded by the Caisse Nationale Maladie des Travailleurs Salariés, Direction Générale de la Santé, MGEN, Institut de la Longévité, Agence Française de Sécurité Sanitaire des Produits de Santé, the Aquitaine and Bourgogne Regional Councils, Fondation de France and the joint French Ministry of Research/INSERM ‘Cohortes et collections de données biologiques’ program. Lille Génopôle received an unconditional grant from Eisai.

AAA: We thank the cohort participants and team members who contributed to this study. Phenotype collection and DNA extraction were supported by the Wellcome Trust, the British Heart Foundation and the Chief Scientist Office of the Scottish Executive. The AAA Trial was performed and the database is maintained by members of the University of Edinburgh Molecular Epidemiology Research Group in the Centre for Population Health Sciences. We also thank staff at the Wellcome Trust Clinical Research Facility in Edinburgh where some of the research clinics and genotyping were undertaken.

AGES: Aging Gene-Environment Susceptibility-Reykjavik Study: The research has been funded by NIA Contract N01-AG-12100 with contributions from NEI, NIDCD and NHLBI, the NIA Intramural Research Program, Hjartavernd (the Icelandic Heart Association) and the Althingi (the Icelandic Parliament).

ARIC: The Atherosclerosis Risk in Communities Study is carried out as a collaborative study supported by National Heart, Lung and Blood Institute Contracts (HHSN268201100005C, HHSN268201100006C, HHSN268201100007C, HHSN268201100008C, HHSN268201100009C, HHSN268201100010C, HHSN268201100011C and HHSN268201100012C), R01HL70825, R01HL087641, R01HL59367 and R01HL086694; National Human Genome Research Institute Contract U01HG004402; and National Institutes of Health Contract HHSN268200625226C. We thank the staff and participants of the ARIC study for their important contributions. Infrastructure was partly supported by Grant Number UL1RR025005, a component of the National Institutes of Health and NIH Roadmap for Medical Research.

ASPS: We thank Ing. Johann Semmler and Irmgard Pölzl for creating the DNA bank and for supervising the quality managementof the biobanking and DNA analyses.The ASPS is funded by the Austrian Science Fond (FWF) Grant Number P20545-P05 and P13180.

BLSA: Baltimore Longitudinal Study of Aging (BLSA): The Baltimore Longitudinal Study of Aging is supported by the Intramural Research Program of the NIH, National Institute on Aging.

Cardiovascular Health Study: This CHS research was supported by NHLBI contracts HHSN268201200036C, HHSN268200800007C, N01HC55222, N01HC85079, N01HC85080, N01HC85081, N01HC85082, N01HC85083, N01HC85086; and NHLBI grants U01HL080295, R01HL087652, R01HL105756, R01HL103612, and R01HL120393 with additional contribution from the National Institute of Neurological Disorders and Stroke (NINDS). Additional support was provided through R01AG023629, R01AG15928, R01AG20098, and R01AG027058 from the National Institute on Aging (NIA). A full list of principal CHS investigators and institutions can be found at CHS-NHLBI.org. The provision of genotyping data was supported in part by the National Center for Advancing Translational Sciences, CTSI grant UL1TR000124, and the National Institute of Diabetes and Digestive and Kidney Disease Diabetes Research Center (DRC) grant DK063491 to the Southern California Diabetes Endocrinology Research Center. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.

CROATIA-Korcula: The CROATIA-Korcula study was funded by grants from the Medical Research Council (UK), European Commission Framework 6 project EUROSPAN (Contract No. LSHG-CT-2006-018947) and Republic of Croatia Ministry of Science, Education and Sports research grants to IR (108-1080315-0302). We would like to acknowledge the invaluable contributions of the recruitment team in Korcula, the administrative teams in Croatia and Edinburgh and the people of Korcula. The SNP genotyping for the CROATIA-Korcula cohort was performed in Helmholtz Zentrum München, Neuherberg, Germany.

CROATIA-Split: The CROATIA-Split study is funded by grants from the Medical Research Council (UK), European Commission Framework 6 project EUROSPAN (Contract No. LSHG-CT-2006-018947) and Republic of Croatia Ministry of Science, Education and Sports research grants to IR (108-1080315-0302). We would like to acknowledge the invaluable contributions of the recruitment team in Split, the administrative teams in Croatia and Edinburgh and the people of Split. The SNP genotyping for the CROATIA-Split cohort was performed by AROS Applied Biotechnology, Aarhus, Denmark.

CROATIA-Vis: The CROATIA-Vis study was funded by grants from the Medical Research Council (UK) and Republic of Croatia Ministry of Science, Education and Sports research grants to IR (108-1080315-0302). We would like to acknowledge the staff of several institutions in Croatia that supported the field work, including but not limited to The University of Split and Zagreb Medical Schools, the Institute for Anthropological Research in Zagreb and Croatian Institute for Public Health. The SNP genotyping for the CROATIA-Vis cohort was performed in the core genotyping laboratory of the Wellcome Trust Clinical Research Facility at the Western General Hospital, Edinburgh, Scotland.

ERF: This study was financially supported by the Netherlands Organization for Scientific Research (NWO), the Internationale Stichting Alzheimer Onderzoek (ISAO), the Hersenstichting Nederland (HSN) and the Centre for Medical Systems Biology (CMSB) in the framework of the Netherlands Genomics Initiative (NGI) and by the Russian Foundation for Basic Research (RFBR). We thank the participants from the Genetic Research in Isolated Populations, Erasmus Rucphen Family, who made this work possible. Also, we thank Petra Veraart for collecting all genealogical data.

FHS: This work was supported by the National Heart, Lung and Blood Institute’s Framingham Heart Study (Contract No. N01-HC-25195) and its contract with Affymetrix, Inc for genotyping services (Contract No. N02-HL-6-4278) and Grants (U01 HL096917 and R01 HL093029). A portion of this research utilized the Linux Cluster for Genetic Analysis (LinGA-II) funded by the Robert Dawson Evans Endowment of the Department of Medicine at Boston University School of Medicine and Boston Medical Center. Analyses reflect intellectual input and resource development from the Framingham Heart Study investigators participating in the SNP Health Association Resource (SHARe) project. This study was also supported by grants from the National Institute of Neurological Disorders and Stroke (NS17950) and the National Institute of Aging (U01 AG049505, AG033193, AG008122, AG16495). The content is solely the responsibility of the authors and does not necessarily represent the official views of NINDS, NHLBI, NIA, NIH or AHA. Dr. Debette is a recipient of a Chaire d'Excellence grant from the Agence National de la Recherche and a grant from the Leducq Foundation.

GENOA: Support for the Genetic Epidemiology Network of Arteriopathy (GENOA) was provided by the National Heart, Lung and Blood Institute (HL054464, HL054457, HL054481, HL071917 and HL87660) and the National Institute of Neurological Disorders and Stroke (NS041558) of the National Institutes of Health. Genotyping was performed at the Mayo Clinic (S.T.T., Mariza de Andrade, Julie Cunningham) and was made possible by the University of Texas Health Sciences Center (Eric Boerwinkle, Megan L Grove-Gaona). We would also like to thank the families that participated in the GENOA study.

GS: We are grateful to the GS Executive Committee Professors Blair H. Smith, David J. Porteous, Sandosh Padmanabhan and Dr. Lynne J. Hocking, and all the families who took part, the general practitioners and the Scottish School of Primary Care for their help in recruiting them, and the whole Generation Scotland team, which includes interviewers, computer and laboratory technicians, clerical workers, research scientists, volunteers, managers, receptionists, healthcare assistants and nurses. Generation Scotland received core support from the Chief Scientist Office of the Scottish Government Health Directorates [CZD/16/6] and the Scottish Funding Council [HR03006].

HBCS: We thank all study participants as well as everybody involved in the Helsinki Birth Cohort Study. Helsinki Birth Cohort Study has been supported by grants from the Academy of Finland, the Finnish Diabetes Research Society, Folkhälsan Research Foundation, Novo Nordisk Foundation, Finska Läkaresällskapet, Signe and Ane Gyllenberg Foundation, University of Helsinki, Ministry of Education, Ahokas Foundation, Emil Aaltonen Foundation, Juho Vainio Foundation and Wellcome Trust (Grant Number WT089062).

Health ABC: This research was supported by NIA Contracts N01AG62101, N01AG62103 and N01AG62106. The genome-wide association study was funded by NIA Grant 1R01AG032098-01A1 to Wake Forest University Health Sciences and genotyping services were provided by the Center for Inherited Disease Research (CIDR). CIDR is fully funded through a federal contract from the National Institutes of Health to The Johns Hopkins University, Contract Number HHSN268200782096C. This research was supported in part by the Intramural Research Program of the NIH, National Institute on Aging.

Hunter: The authors would like to thank the men and women participating in the HCS as well as all the staff, investigators and collaborators who have supported or been involved in the project to date. The cohort was made possible with support from the University of Newcastle's Strategic Initiative Fund, the Vincent Fairfax Family Foundation and the Hunter Medical Research Institute.

InCHIANTI: The Invechhiare in Chianti (InCHIANTI) Study was supported as a targeted project (ICS 110.1RS97.71) by the Italian Ministry of Health, by the US National Institute on Aging (Contracts N01[AG]916413, N01[AG] 821336, 263 MD 9164 13, and 263 MD 821336), and, in part, by the Intramural Research Program, National Institute on Aging, National Institutes of Health.

LBC1921/LBC1936: We thank the cohort participants and team members who contributed to these studies. Phenotype collection in the Lothian Birth Cohort 1921 was supported by the BBSRC, The Royal Society and The Chief Scientist Office of the Scottish Government. Phenotype collection in the Lothian Birth Cohort 1936 was supported by Research Into Ageing (continues as part of Age UK The Disconnected Mind project). Genotyping of the cohorts was funded by the UK Biotechnology and Biological Sciences Research Council (BBSRC). The work was undertaken by The University of Edinburgh Centre for Cognitive Ageing and Cognitive Epidemiology, part of the cross council Lifelong Health and Wellbeing Initiative (G0700704/84698). Funding from the BBSRC, Engineering and Physical Sciences Research Council (EPSRC), Economic and Social Research Council (ESRC) and MRC is gratefully acknowledged.

MAS: We would like to acknowledge and thank the Sydney MAS participants and the Research Team for their contributions and assistance. We would like to specifically acknowledge the support and contributions of Professor Henry Brodaty (Chief Investigator), Dr Simone Reppermund (Study Co-ordinator), Professor Peter Schofield, Dr Arezoo Assareh and Dr John Kwok to this work. DNA was extracted by Genetic Repositories Australia, an Enabling Facility supported by NHMRC Grant 401184. DNA sample preparation was undertaken in the laboratory of Professor Peter Schofield and Dr John Kwok, Neuroscience Research Australia, with the assistance of Dr Arezoo Assareh. Genotyping was performed by the Ramaciotti Centre, University of New South Wales. Sydney MAS is supported by the Australian National Health & Medical Research Council Program Grants 350833 and 568969. Karen Mather is supported by the Capacity Building Grant 568940. Nicola Armstrong is supported by the NHMRC Project Grant 525453.

Hippocampal eQTL: The hippocampal gene expression study was supported by the German Federal Ministry of Education and Research (BMBF) through the Integrated Genome Research Network (IG) MooDS (Systematic Investigation of the Molecular Causes of Major Mood Disorders and Schizophrenia, under the auspices of the National Genome Research Network plus (NGFNplus)).

NHS: This study was supported by research Grants CA87969, CA49449, HL34594, U01HG004399, DK058845, CA65725, CA67262, CA50385, 5UO1CA098233, EY09611, EY015473, HG004728, HL35464, CA55075, CA134958 and DK070756 from the National Institutes of Health. The genotyping was partly supported by an unrestricted grant from Merck Research Laboratories. Dr Sun is supported by career development award K99HL098459 from the National Heart, Lung and Blood Institute. Supported in part by NIH.

ORCADES: ORCADES was supported by the Chief Scientist Office of the Scottish Government, the Royal Society, the MRC Human Genetics Unit, Arthritis Research UK and the European Union framework program 6 EUROSPAN project (Contract No. LSHG-CT-2006-018947). DNA extractions were performed at the Wellcome Trust Clinical Research Facility in Edinburgh. We would like to acknowledge the invaluable contributions of Lorraine Anderson and the research nurses in Orkney, the administrative team in Edinburgh and the people of Orkney.

PROSPER: The PROSPER study was supported by an investigator initiated grant obtained from Bristol-Myers Squibb. Prof. Dr JW Jukema is an Established Clinical Investigator of the Netherlands Heart Foundation (Grant 2001 D 032). Support for genotyping was provided by the seventh framework program of the European commission (Grant 223004) and by the Netherlands Genomics Initiative (Netherlands Consortium for Healthy Aging Grant 050-060-810).

RS: The generation and management of GWAS genotype data for the Rotterdam Study is supported by the Netherlands Organisation of Scientific Research NWO Investments (nr. 175.010.2005.011, 911-03-012). This study is funded by the Research Institute for Diseases in the Elderly (014-93-015; RIDE2), the Netherlands Genomics Initiative (NGI)/Netherlands Organisation for Scientific Research (NWO) project nr. 050-060-810. We thank Pascal Arp, Mila Jhamai, Marijn Verkerk, Lizbeth Herrera and Marjolein Peters for their help in creating the GWAS database, and Karol Estrada and Maksim V. Struchalin for their support in creation and analysis of imputed data. The Rotterdam Study is funded by Erasmus Medical Center and Erasmus University, Rotterdam, Netherlands Organization for the Health Research and Development (ZonMw), the Research Institute for Diseases in the Elderly (RIDE), the Ministry of Education, Culture and Science, the Ministry for Health, Welfare and Sports, the European Commission 49 (DG XII), and the Municipality of Rotterdam. The authors are grateful to the study participants, the staff from the Rotterdam Study and the participating general practitioners and pharmacists. Dr Ikram was supported by a ZonMW Veni Grant: 916.13.054.

RUSH: Supported in part by NIA Grants P30AG10161, R01AG15819, R01AG17917, R01AG30146, K08AG34290 and K25AG41906.

SHIP: SHIP is part of the Community Medicine Research net of the University Medicine of Greifswald, Germany, which is funded by the Federal Ministry of Education and Research (grants no. 01ZZ9603, 01ZZ0103, and 01ZZ0403), the Ministry of Cultural Affairs as well as the Social Ministry of the Federal State of Mecklenburg-West Pomerania. The SHIP authors are grateful to Holger Prokisch and Thomas Meitinger (Helmholtz Zentrum München) for the genotyping of the SHIP-TREND cohort.

WGHS: The WGHS is supported by HL043851 and HL080467 from the National Heart, Lung and Blood Institute and CA047988 from the National Cancer Institute, the Donald W Reynolds Foundation and the Fondation Leducq, with collaborative scientific support and funding for genotyping provided by Amgen.

The study sponsors had no role in the study design, the collection, analysis, and interpretation of data; writing the report, or the decision to submit the report for publication.

Author Contributions

Study concept and design were performed by CAIV, JB, SD, MS, AVS, JCB, GD, ST, CW, BHS, VG, JWJ, TBH, OLL, IF, JTB, GH, STT, KY, JvS, LHC, SLRK, DSK, PWS, DJS, JMS, LJH, GE, RS, RJS, AP, RFG, BAO, JIR, MMN, AH, RGJW, PAW, AGU, BMP, HJG, SB, DIC, LF, JRA, IR, CH, AFW, JFW, MF, DAB, IJD, MAI, LJL, ALF, SS, CMvD and THM. Acquisition of data was carried out by CAIV, MS, ST, KP, OP, LZ, PH, JK, JL, SMR, FG, MS, BHS, VG, JWJ, PLDeJ, TBH, OLL, JTB, MKJ, RA, RSNF, SH, STT, JvS, LHC, SLRK, DSK, WMM, GH, PWS, DCL, PR, AJG, AP, LJH, NJA, SMcL, DJP, JMS, GE, RS, RJS, NAK, AP, JGE, RFG, BAO, AB, JIR, MMN, AH, PES, PAW, AGU, BMP, HJG, SB, DIC, FG, KR, JFP, PSS, LF, JRA, CH, SC, LF, JFW, MF, DAB, MAI, SS, CMvD and THM. Statistical analysis and interpretation of the data were performed by CAIV, JB, SD, MS, AVS, JCB, GD, ST, JS, CW, LBC, YL, VV, MK, LZ, JK, JL, DL, COS, KM, VC, QS, LMR, CO, QY, SSM, NA, OS,AT, NK, RSNF, WZ, KY, KL, SLRK, EGH, TT, JW, NJA, LCP, RJS, NK, AP, YCH, LY, ALdeS, AB, MG, MMN, JCL, PSS, JRA, CH, JD, AJMDeC, IJD, MAI and THM. The manuscript was drafted by CAIV, JB, SD, MS, JCB, NA, HS, SS, CMvD and THM. Critical revision of the manuscript was performed by CAIV, JB, SD, MS, AVS, JCB, GD, ST, JS, CV, LBC, YL, VV, MK, KP, OP, LZ, PH, JK, JL, DL, COS, KAM, VC, QS, SMR, LMR, CO, MS, BHS, VG, QY, SSM, JWJ, PLDeJ, TBH, DCL, NA, LHC, OS, OLL, RS, AT, IF, NK, JTB, MJK, RA, RSNF, SH, MN, WZ, STT, KY, KL, JCvS, SLRK, DSK, WMM, GH, EGH, PWS, TT, DJS, JW, PR, AJG, AP, JMS, LJH, NJA, SMcL, JMS, LCP, GE, RJS, NAK, AP, YCH, JGE, AP, RFG, BAO, LY, ALDeS, AB, MG, JIR, MN, AH, PES, RGJW, BMB, PAW, AGU, BMP, HJG, SB, DIC, FG, KR, JCL, DJP, JFP, PSS, LF, JRA, IR, CH, AFW, JFW, SC, LF, HS, JD, AJMDeC, MF, DAB, ID, MAI, LJL, AF, SS, CMvD and THM. Funding was obtained by ST, SMR, BHS, VG, JWJ, PLDeJ, TBH, OLL, IF, JTB, MN, STT, JCvS, SLRK, GH, PWS, JMS, AP, JGE, BAO, JIR, MMN, AH, PES, RGJW, BMB, PAW, AGU, BMP, HJG, SB, DIC, FG, KR, PSS, JRA, IR, AFW, JFW, AJMDeC, DAB, IJD, MAI, LJL, ALF, SS, CMvD and THM.

Author information

Authors and Affiliations

Authors

Consortia

Corresponding author

Correspondence to T H Mosley.

Ethics declarations

Competing interests

The authors declare no conflict of interest.

Additional information

Supplementary Information accompanies the paper on the Molecular Psychiatry website

Supplementary information

PowerPoint slides

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Ibrahim-Verbaas, C., Bressler, J., Debette, S. et al. GWAS for executive function and processing speed suggests involvement of the CADM2 gene. Mol Psychiatry 21, 189–197 (2016). https://doi.org/10.1038/mp.2015.37

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/mp.2015.37

This article is cited by

Search

Quick links